Lrig1 抗体 (AA 35-220)
Quick Overview for Lrig1 抗体 (AA 35-220) (ABIN6143319)
抗原
See all Lrig1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 35-220
-
序列
- AGPRAPCAAA CTCAGDSLDC GGRGLAALPG DLPSWTRSLN LSYNKLSEID PAGFEDLPNL QEVYLNNNEL TAVPSLGAAS SHVVSLFLQH NKIRSVEGSQ LKAYLSLEVL DLSLNNITEV RNTCFPHGPP IKELNLAGNR IGTLELGAFD GLSRSLLTLR LSKNRITQLP VRAFKLPRLT QLDLNR
-
交叉反应
- 人, 小鼠
-
产品特性
- Polyclonal Antibodies
-
免疫原
- Recombinant fusion protein containing a sequence corresponding to amino acids 35-220 of human LRIG1 (NP_056356.2).
-
亚型
- IgG
-
-
-
-
应用备注
- WB,1:1000 - 1:2000
-
说明
-
HIGH QUALITY
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
-
别名
- LRIG1
-
背景
- Acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.,LRIG1,LIG-1,LIG1,Cancer,Tumor suppressors,LRIG1
-
分子量
- 116 kDa/119 kDa
-
基因ID
- 26018
-
UniProt
- Q96JA1
抗原
-